Letrozole (CGS 20267), a New Oral Aromatase Inhibitor for the Treatment of Advanced Breast Cancer in Postmenopausal Patients

Acta Oncologica - United Kingdom
doi 10.3109/02841869609083962
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited

Related search

Anastrozole as Aromatase Inhibitor – New Approaches to Breast Cancer Treatment in Postmenopausal Women

Nowotwory
Cancer ResearchOncology
2019English

Deficiencies in Immunoassay Methods Used to Monitor Serum Estradiol Levels During Aromatase Inhibitor Treatment in Postmenopausal Breast Cancer Patients

SpringerPlus
Multidisciplinary
2013English

Sequential Changes in Gene Expression Profiles in Breast Cancers During Treatment With the Aromatase Inhibitor, Letrozole

Pharmacogenomics Journal
Molecular MedicineGeneticsPharmacology
2010English

Combination of Aromatase Inhibitors With Metronomic Capecitabine: A New Chemoendocrine Treatment for Advanced Breast Cancer

Journal of Cancer Therapy
2019English

Accumulation of P53 Is Prognostic for Aromatase Inhibitor Resistance in Early-Stage Postmenopausal Patients With ER-positive Breast Cancer

OncoTargets and Therapy
OncologyPharmacology
2015English

Guidelines for Osteoprotection in Breast Cancer Patients on an Aromatase Inhibitor

Breast Care
SurgeryOncology
2010English

Efficacy of Adjuvant Aromatase Inhibitor in Hormone Receptor-Positive Postmenopausal Breast Cancer Patients According to the Body Mass Index

British Journal of Cancer
Cancer ResearchOncology
2012English

Review of Hormone-Based Treatments in Postmenopausal Patients With Advanced Breast Cancer Focusing on Aromatase Inhibitors and Fulvestrant

ESMO Open
Cancer ResearchOncology
2016English

(557) Auricular Point Acupressure to Manage Aromatase Inhibitor-Induced Arthralgia in Postmenopausal Breast Cancer Survivors

Journal of Pain
NeurologyAnesthesiologyPain Medicine
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy